OFFICE SPACE LICENSE AGREEMENTOffice Space License Agreement • March 11th, 2016 • Actinium Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Office Space License Agreement (“Agreement”) dated March 10, 2016 and effective as of January 1, 2016, by and between RELMADA THERAPEUTICS, INC., a Nevada Corporation (“Relmada”), and ACTINIUM PHARMACEUTICALS, INC., a Delaware Corporation (“Client”), with respect to the license of the portion identified in Exhibit A (the “Client Area”) of the portion of the 7th Floor of the office building located at 275 Madison Avenue, New York, New York (“Building”), upon and subject to the following terms, covenants and conditions.
